BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9209320)

  • 21. A model for alignment of Env V1 and V2 hypervariable domains from human and simian immunodeficiency viruses.
    Lamers SL; Sleasman JW; Goodenow MM
    AIDS Res Hum Retroviruses; 1996 Aug; 12(12):1169-78. PubMed ID: 8844021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular subtyping of the HIV-1 V3 loop sequences detected in HIV-1-positive patients in southern Taiwan.
    Shieh B; Lee CM; Chen YM; Su IJ; Li C
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 May; 30(2):106-14. PubMed ID: 10592816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of V2 mutations on escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary human immunodeficiency virus type 1 isolate.
    Shibata J; Yoshimura K; Honda A; Koito A; Murakami T; Matsushita S
    J Virol; 2007 Apr; 81(8):3757-68. PubMed ID: 17251298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo sequence variability of human immunodeficiency virus type 1 envelope gp120: association of V2 extension with slow disease progression.
    Shioda T; Oka S; Xin X; Liu H; Harukuni R; Kurotani A; Fukushima M; Hasan MK; Shiino T; Takebe Y; Iwamoto A; Nagai Y
    J Virol; 1997 Jul; 71(7):4871-81. PubMed ID: 9188549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of natural sequence variation in the V2 region of the envelope protein of human immunodeficiency virus type 1 on syncytium induction: a mutational analysis.
    Andeweg AC; Boers PH; Osterhaus AD; Bosch ML
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1901-7. PubMed ID: 7636471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples.
    Saracino A; Monno L; Punzi G; Cibelli DC; Tartaglia A; Scudeller L; Brindicci G; Lagioia A; Scotto G; Angarano G
    Virus Res; 2007 Dec; 130(1-2):34-42. PubMed ID: 17582634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of in vivo plasma and peripheral blood mononuclear cell HIV-1 quasi-species to short-term tissue culture isolates: an analysis of tat and C2-V3 env regions.
    Sabino E; Pan LZ; Cheng-Mayer C; Mayer A
    AIDS; 1994 Jul; 8(7):901-9. PubMed ID: 7946099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage.
    Xiao L; Owen SM; Goldman I; Lal AA; deJong JJ; Goudsmit J; Lal RB
    Virology; 1998 Jan; 240(1):83-92. PubMed ID: 9448692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positioning of positively charged residues in the V3 loop correlates with HIV type 1 syncytium-inducing phenotype.
    Bhattacharyya D; Brooks BR; Callahan L
    AIDS Res Hum Retroviruses; 1996 Jan; 12(2):83-90. PubMed ID: 8834457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and biological characterization of HIV-1 BG intersubtype recombinants and other genetic forms circulating in Galicia, Spain.
    Pérez-Alvarez L; Muñoz M; Delgado E; Miralles C; Ocampo A; García V; Thomson M; Contreras G; Nájera R;
    J Med Virol; 2006 Dec; 78(12):1520-8. PubMed ID: 17063519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype.
    Kuiken CL; de Jong JJ; Baan E; Keulen W; Tersmette M; Goudsmit J
    J Virol; 1992 Jul; 66(7):4622-7. PubMed ID: 1602564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence diversity of V1 and V2 domains of gp120 from human immunodeficiency virus type 1: lack of correlation with viral phenotype.
    Wang N; Zhu T; Ho DD
    J Virol; 1995 Apr; 69(4):2708-15. PubMed ID: 7884929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV type 1 V3 variation dynamics in vivo: long-term persistence of non-syncytium-inducing genotypes and transient presence of syncytium-inducing genotypes during the course of progressive AIDS.
    Ida S; Gatanaga H; Shioda T; Nagai Y; Kobayashi N; Shimada K; Kimura S; Iwamoto A; Oka S
    AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1597-609. PubMed ID: 9430252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania.
    Lukashov VV; Cornelissen MT; Goudsmit J; Papuashvilli MN; Rytik PG; Khaitov RM; Karamov EV; de Wolf F
    AIDS; 1995 May; 9(5):435-9. PubMed ID: 7639968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular analysis of the principal neutralization epitope (V3 loop) of human immunodeficiency virus type 1 in Argentina].
    Gómez Carrillo M; Piccardo C; Libonatti O
    Rev Argent Microbiol; 1992; 24(2):91-101. PubMed ID: 1298019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR.
    Fouchier RA; Brouwer M; Broersen SM; Schuitemaker H
    J Clin Microbiol; 1995 Apr; 33(4):906-11. PubMed ID: 7790458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection in context: patterns of natural selection in the glycoprotein 120 region of human immunodeficiency virus 1 within infected individuals.
    Templeton AR; Reichert RA; Weisstein AE; Yu XF; Markham RB
    Genetics; 2004 Aug; 167(4):1547-61. PubMed ID: 15342497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and characterization of two divergent infectious molecular clones of HIV type 1 longitudinally obtained from a seropositive patient by a progressive amplification procedure.
    Chen M; Singh MK; Balachandran R; Gupta P
    AIDS Res Hum Retroviruses; 1997 Jun; 13(9):743-50. PubMed ID: 9171218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary structure of the V3 region of gp120 from sequential human immunodeficiency virus type 1 isolates obtained from patients from the time of seroconversion.
    Distler O; McQueen PW; Tsang ML; Evans LA; Hurren L; Byrne C; Penny R; Cooper DA; Delaney SF
    J Infect Dis; 1995 Nov; 172(5):1384-7. PubMed ID: 7594684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence analysis of the V1/V2 and V3 domains in an HIV-seronegative AIDS patient.
    Vallejo A; Bravo R; Heredia A; Soriano V; Dronda F; Hewlett IK
    AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1539-41. PubMed ID: 8679300
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.